The Third Affiliated Hospital of Southern Medical University

Guangzhou 510665

2 studies enrolling now · 2 studies all time

What they study most

Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Kidney Disease, Chronic, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Prostate Cancer

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now